v3.19.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 2,337,593 $ 743,429
Accounts receivable, net 1,658,919 1,978,456
Accounts receivable, related party, net 100,000
Prepaid expenses and other current assets 406,563 414,541
Deferred cost, related party 50,000
Inventories, net 1,270,480 1,921,051
Advances on contracts 530,114 648,783
Operating lease-right of use assets 92,830
Total current assets 6,296,499 5,856,260
Furniture, fixtures and equipment, net 65,668 82,557
Patents, net 408,767 435,273
Other assets 17,355 26,878
Total assets 6,788,289 6,400,968
Current liabilities:    
Accounts payable 1,192,823 1,205,396
Accounts payable, related party 1,283,367 1,663,849
Accrued expenses and other payables 1,464,846 1,481,715
Accrued expenses, related party 125,428
Operating lease liabilities-current 92,830
Deferred profit, related party 372,700 421,800
Deferred revenue, related party 100,000
Derivative liability 1,418,863
Total current liabilities 5,950,857 4,872,760
Total liabilities 5,950,857 4,872,760
Commitments and contingencies
Stockholders’ equity    
Series A convertible preferred stock, par value $.001, authorized 5,000,000 shares, 0 and 7,000 shares issued and outstanding as of June 30, 2019 and December 31, 2018. 7
Common stock, par value $.001; authorized 50,000,000 shares; 47,132,220 shares issued, 0 shares to be issued and 47,098,886 shares outstanding as of June 30, 2019 ; 33,859,034 shares issued, 2,470,565 shares to be issued and 33,825,701 shares outstanding as of December 31, 2018; 47,132 36,330
Additional paid in capital 89,559,585 88,414,718
Accumulated deficit (87,823,965) (85,999,929)
Treasury stock, at cost, 33,333 shares (911,516) (911,516)
Total Milestone Scientific Inc. stockholders' equity 871,236 1,539,610
Noncontrolling interest (33,804) (11,402)
Total stockholders’ equity 837,432 1,528,208
Total liabilities and stockholders’ equity $ 6,788,289 $ 6,400,968

Source